IP Library › Granted Patent US 9,402,607
Granted Patent B2
US 9,402,607 · App. 14/321,091 · Granted Aug 2, 2016

Impedance guided tunneling tool

Inventors: Karel F. A. A. Smits (Munstergeleen, NL); Jean Joseph Gerardus Rutten (Bocholtz, NL); Mark Lazeroms (Vroenhoven-Riemst, BE)
Assignee: Medtronic, Inc.
A61B17/02A61B19/46A61N1/046A61N1/05A61N1/0504A61B17/3468A61B2017/00026A61B2017/320044A61B2017/320056A61B2019/462
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,402,607
App. No.
14/321,091
Granted
Aug 2, 2016
Kind
B2
Abstract

A system includes a first electrode at a tip of a tunneling tool and a second electrode. The system includes a circuit configured to determine whether the tip of the tunneling tool is within subcutaneous fat tissue or muscle tissue of a patient based on a measurement of an impedance between the first electrode and the second electrode.

Claims (27)

1. A system comprising:

a first electrode at a tip of a tunneling tool, wherein the first electrode comprises a stylet within a central lumen of a lead;

a second electrode attached to the tunneling tool, wherein the second electrode comprises a coil of the lead; and

a circuit configured to determine whether the tip of the tunneling tool is within subcutaneous fat tissue or muscle tissue of a patient based on a measurement of an impedance between the first electrode and the second electrode.

2. The system of claim 1 , wherein the circuit comprises an audible indicator configured to indicate whether the tip of the tunneling tool is within subcutaneous fat tissue or muscle tissue based on the impedance measurement.

3. The system of claim 1 , wherein the circuit comprises a visible indicator configured to indicate whether the tip of the tunneling tool is within subcutaneous fat tissue or muscle tissue based on the impedance measurement.

4. The system of claim 1 , wherein the circuit comprises a voltage source and a meter, the voltage source configured for applying a voltage across the first electrode and the second electrode, the meter configured to measure a current between the first electrode and the second electrode for measuring the impedance between the first electrode and the second electrode.

5. The system of claim 4 , wherein the voltage source comprises an AC voltage source.

6. A system comprising:

a tunneling tool including a first electrode at a tip of a tunneling tool, and a second electrode on the tunneling tool spaced from the first electrode, wherein the second electrode is a coil electrode, the tunneling tool configured to create space between the subcutaneous and muscular plane in a patient to implant a subcutaneous device;

an impedance measurement system coupled to the first electrode and the second electrode, the impedance measurement system including a circuit configured to determine whether the tip of the tunneling tool is within subcutaneous fat tissue or muscle tissue of the patient based on a measurement of impedance between the first electrode and the second electrode.

7. The system of claim 6 , wherein the tunneling tool comprises a lead system.

8. The system of claim 7 , wherein the lead system includes a lead having a central lumen, and a removable stylet within the central lumen.

9. The system of claim 8 , wherein the second electrode comprises a coil of the lead.

10. The system of claim 8 , wherein the first electrode is located at an end of the stylet.

11. The system of claim 10 , wherein the second electrode comprises a coil electrode located along the lead, and further comprising an insulation material that isolates the coil electrode from the stylet.

12. The system of claim 6 , comprising:

an implantable device positionable along the tunneling tool.

13. The system of claim 6 , comprising:

a monitor coupled to the measuring system having an indicator for indicating whether the tip of the tunneling tool is within subcutaneous fat tissue.

14. The system of claim 6 , wherein the impedance measurement system includes an AC voltage source electrically coupled to at least the first electrode or the second electrode, such that a frequency of the AC voltage source may be increased for greater distinction between measurement of the subcutaneous fat tissue and muscle tissue.

15. The system of claim 14 , further comprising a meter positioned between the AC voltage source and one of the first electrode or the second electrode.

16. A system comprising:

a tunneling tool including a first electrode at a tip of a tunneling tool, and a second electrode on the tunneling tool spaced from the first electrode, the tunneling tool configured to create space between the subcutaneous and muscular plane in a patient to implant a subcutaneous device;

an impedance measurement system coupled to the first electrode and the second electrode, the impedance measurement system including a circuit configured to determine whether the tip of the tunneling tool is within subcutaneous fat tissue or muscle tissue of the patient based on a measurement of impedance between the first electrode and the second electrode;

wherein the tunneling tool comprises a lead system that includes a lead having a central lumen, and a removable stylet within the central lumen, wherein the first electrode is located at an end of the stylet; and wherein the second electrode comprises a coil electrode located along the lead, and further comprising an insulation material that isolates the coil electrode from the stylet; and

wherein the impedance measurement system includes an AC voltage source electrically coupled to at least the first electrode or the second electrode, such that a frequency of the AC voltage source may be increased for greater distinction between measurement of the subcutaneous fat tissue and muscle tissue.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 8, 2015
From: SMITS, KAREL F.A.A.; GERARDUS RUTTEN, JEAN JOSEPH; LAZEROMS, MARK
To: MEDTRONIC, INC.
Reel/Frame 035802/0841 →
Continuity (2)
Division 12262560 · Oct 31, 2008
Related Publication 20140316429A1 · Oct 23, 2014